FdaApplication

ANDA 209064

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTWI PHARMACEUTICALS INC
application_typeANDA
approval_date2026-01-21

Products (1)

ProductActive ingredientStrengthDosage form
CYCLOSPORINECYCLOSPORINE0.05%EMULSION;OPHTHALMIC

1 product